Wednesday, April 7, 2021, 5:00 p.m. – 6:30 p.m
This seminar is free. Pre-registration is required. Register in advance at this zoom link. Maximum capacity is 100 participants.
Panelists:
Dr. Jeff Werling, Director of Macroeconomic Analysis, Congressional Budget Office
Dr. Wendy Edelberg, Director, The Hamilton Project, Brookings Institution
During the year from March 2020 until March 2021 over thirty million cases and 540 thousand deaths occurred in the United States from the covid-19 pandemic and 122 million cases and 2,690 deaths occurred worldwide. It was the worst health crisis since the influenza pandemic of 1918.
The economic devastation has been severe. Total U.S. nonfarm employment fell by 20.5 million to the low point in April 2020. The COVID-19 pandemic could result in net losses in the range of $3.2 trillion to $4.8 trillion in U.S. real gross domestic product (GDP) over the course of two years, according to estimates from a new University of Southern California study.
Vaccines for Covid-19 give hope that the world can return to normal. Moderna and Pfizer-BioNTech developed mRNA vaccines. Johnson & Johnson, the third vaccine in the U.S., was approved for emergency use in February 2021.
Our panelists will present perspectives on these issues, followed by Q&A and discussion.
Dr. Jeff Werling is Director of Macroeconomic Analysis at the Congressional Budget Office. Prior to that position Dr. Werling was President of the Interindustry Economic Research Fund Inc. Werling received a Ph.D. in Economics at the University of Maryland in 1992.
Dr. Wendy Edelberg is Director of the Hamilton Project at the Brooking Institution and Senior Fellow in Economic Studies. Prior to that appointment Dr. Edelberg was Chief Economist at the Congressional Budget Office. Edelberg received a Ph.D. in economics from the University of Chicago.
